Join the Lamictal CD group to help and get support from people like you.
Lamictal CD News
Autism Risk May Rise With In Utero Exposure to Antiseizure Meds
WEDNESDAY, March 20, 2024 – The incidence of autism spectrum disorder is higher among children exposed to topiramate in the second half of pregnancy compared with the general population of children...
FDA Medwatch Alert: Drug Safety Communication: Lamictal (lamotrigine) - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease
March 31, 2021 – A U.S. Food and Drug Administration (FDA) review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart disease who...
FDA Medwatch Alert: Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles
January 10, 2020 – Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Lamotrigine 100 mg Tablets, Lot # 331771 (expiration date June 2021) in 100 coun...
FDA Medwatch Alert: Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction
ISSUE: The FDA is warning that the medicine Lamictal (lamotrigine) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s i...
FDA Medwatch Alert: Lamotrigine Orally Disintegrating Tablet 200 mg by Impax: Recall - Incorrect Labeling of Blister Cards
ISSUE: Impax Laboratories, Inc. issued a voluntary nationwide retail level recall on August 19, 2016 for one lot of Lamotrigine Orally Disintegrating Tablet (ODT) 200 mg, NDC 0115-1529-08, Lot #...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Bipolar Disorder, Lennox-Gastaut Syndrome, Seizure Prevention, Seizure Prophylaxis, Epilepsy